BIOTECHNOLOGY VALUE FUND II LP
SEC CIK 1102444 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Dir, See Remarks, Footnotes | 2.49M | $15.43M | — | 2 | 2022-08-22 | 2023-01-11 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
BIOTECHNOLOGY VALUE FUND II LP made no open-market trades at KYMR in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-13 | 2023-01-11+ | KYMR | Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP | Dir, See Remarks, Footnotes | P - Purchase | $30.51 | +41.0K | 2.49M | +2% | +$1.25M |
| M | 2022-08-23 | 2022-08-22 | KYMR | Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP | Dir, See Remarks, Footnotes | P - Purchase | $26.00 | +545.5K | 1.86M | +41% | +$14.18M |
Purchase Sale Sale after option exercise All abbreviations